Back to TEVA Stock Lookup

TEVA Related Analyst Comments

Feb 12, 2013 01:15 PM Bristol-Myers' Baraclude News Could Be Positive for Teva Pharma (TEVA) - Analyst

Dec 12, 2012 02:26 PM Investors Scoff At Teva's (TEVA) Cost Cutting Plans

Dec 10, 2012 09:30 AM Investor Meeting is Potential Catalyst for Teva (TEVA)

Dec 3, 2012 11:14 AM Teva Pharma (TEVA) Investors Look To Analyst Day

Oct 16, 2012 12:54 PM Canaccord Genuity Cuts Price Target on Teva (TEVA)

Oct 1, 2012 06:22 AM Investors Focus on Shire (SHPG) as Generic Adderall XR Unlikely This Year

Sep 12, 2012 09:23 AM Leerink Swann Maintains an 'Outperform' on Teva Pharma (TEVA); Review with Patent Specialist

Sep 10, 2012 08:46 AM Needham & Company Maintains a 'Buy' on Sagent Pharmaceuticals (SGNT); Getting Some Mojo Back

Sep 10, 2012 08:43 AM Needham & Company Maintains a 'Strong Buy' on Mylan (MYL); Detrol LA Settlement Provides Small Dose of Certainty

Aug 24, 2012 08:05 AM Needham & Company Maintains a 'Hold' on Par Pharmaceutical (PRX); Is Endo (ENDP) the 'Mystery Bidder'

Aug 23, 2012 09:17 AM Canaccord Genuity on Life Sciences/Pharmaceutical: Catalysts to Push TEVA and IPXL Higher in 2H

Aug 3, 2012 01:45 PM Oppenheimer Maintains a 'Perform' on Teva Pharma (TEVA); Wait for Clarity on Pipeline

Aug 3, 2012 10:33 AM Canaccord Genuity Maintains a 'Buy' on Teva Pharma (TEVA); A Little Reaction or Side Effect?

Aug 3, 2012 09:45 AM Needham & Company Maintains a 'Hold' on Teva Pharma (TEVA); European Generics Are Bottoming & Downside Risks Shrink

Jul 20, 2012 08:31 AM Needham & Company maintains a 'Strong Buy' on Mylan (MYL); PRX Grossly Undervalued by TGP, MYL/PRX Instead As Strong Combo

Jun 26, 2012 11:05 AM UBS Defends Momenta Pharmaceuticals (NASDAQ: MNTA); Negative News Largely In Stock

Jun 25, 2012 12:46 PM UBS Maintains a 'Buy' on Teva Pharma (TEVA); The Decision's In

Jun 25, 2012 09:56 AM Canaccord Genuity on Life Sciences: Generic Adderall XR Approval Offers Several Cross-stock Implications

Jun 25, 2012 09:01 AM Canaccord Genuity Reiterates a 'Buy' on Teva Pharma (TEVA); Win Now A Reality

Jun 21, 2012 10:53 AM Canaccord Genuity on Life Sciences/Specialty Pharma: Top Summer Catalyst-Driven Ideas To Trump 'Macro' Influence

Jun 19, 2012 03:48 PM Barclays on U.S. Specialty Pharmaceuticals: Muddling Now, but Opportunity Remains

Jun 18, 2012 08:36 AM Deutsche Bank Revists The Story on Teva Pharma (TEVA); Many Catalysts Ahead, Floor Established at $35

Jun 15, 2012 08:26 AM Canaccord Genuity Reiterates a 'Buy' on Teva Pharma (TEVA); Top-Line Phase III Results From GALA Study

Jun 12, 2012 08:59 AM Canaccord Genuity Maintains a 'Buy' on Teva Pharma (TEVA); Vision Becoming More Clear After Meeting W/ CEO

May 30, 2012 07:36 AM Needham & Company maintains a 'Strong Buy' on Par Pharmaceutical (PRX); Defending Core Fundamentals Despite Setback From Lovaza Litigation

May 29, 2012 08:24 AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Copaxone Preview

May 25, 2012 01:21 PM Barclays Maintains an 'Equalweight' on Teva Pharma (TEVA); Adjusting Estimates After Business Update

May 25, 2012 10:52 AM UBS Maintains a 'Buy' on Teva Pharma (TEVA); CEO Highlights From Conference Call

May 25, 2012 09:39 AM Canaccord Genuity Maintains a 'Buy' on Teva Pharma (TEVA); Adjusting Estimates; Copaxone Still In Focus

May 25, 2012 07:55 AM Needham & Company Maintains a 'Hold' on Teva Pharma (TEVA); Adjusting Estimates

May 21, 2012 10:05 AM Canaccord Genuity on Pharmaceuticals: Generic Valuation at Historical Trough Level Ahead of Meetings

May 17, 2012 02:44 PM Auriga Reiterates a 'Buy' on Spectrum Pharmaceuticals (SPPI); Generic Leucovorin Shortage Continues

May 11, 2012 01:26 PM Barclays on Healthcare: Top Takeaways from our Second Annual Therapeutics Symposium

May 10, 2012 11:11 AM Canaccord Genuity on Specialty Pharma: TEVA's Q1 Effect on Specialty Pharma (TEVA, WPI, PRGO & MYL)

May 4, 2012 11:42 AM Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Focus Moves to Copaxone Trial

May 1, 2012 02:39 PM Cantor Fitzgerald Maintains a 'Buy' on Warner Chilcott (WCRX); Let's Make It Official

Apr 19, 2012 10:07 AM Canaccord Genuity on Specialty Pharmaceutical: Top Picks Have Less Volatility With Earnings

Apr 9, 2012 02:10 PM Barclays on U.S. Specialty Pharmaceuticals: Model Adjustments on MYL, PRX, TEVA, & WCRX

Apr 9, 2012 09:59 AM Canaccord Genuity on Life Sciences/Specialty Pharmaceuticals Modafinil Decision Adds EPS Headwind to MYL, Benefit to TEVA

Apr 4, 2012 11:23 AM Canaccord Genuity on Life Sciences/Specialty Pharma: What an Actavis Deal Could Mean to Watson (WPI) and the Sector

Mar 21, 2012 01:36 PM Auriga Reiterates a 'Buy' on Spectrum Pharmaceuticals (SPPI); February Demand for Fusilev Hits Record

Mar 20, 2012 09:59 AM Standpoint Research Reiterates a 'Buy' on Teva Pharma (TEVA); Issues of Uncertainty Overblown

Feb 16, 2012 10:04 AM Canaccord Genuity Reiterates a 'Buy' on Teva Pharma (TEVA); Thesis Continues Playing Out - Copaxone Decision Key to Next Leg Up

Feb 16, 2012 08:57 AM Needham & Company Maintains a 'Strong Buy' on Teva Pharma (TEVA); Momentum Carry-Over into 2012 Could Provide Upside to Current Expectations

Jan 17, 2012 10:43 AM Canaccord Genuity on Specialty Pharma: 5 Themes for 2012; 4 Best Stock Ideas

Jan 12, 2012 01:55 PM UBS on U.S. Pharma – Large Cap and Specialty: 4Q11 Preview: Things Still Look Interesting

Dec 23, 2011 07:43 AM Jefferies Sees Favorable Copaxone Ruling is Only Catalyst to Move Shares of Teva Pharm (TEVA)

Dec 22, 2011 07:51 AM Needham & Company Maintains a 'Strong Buy' on Teva Pharma (TEVA); Revamped Financial Guidance Largely In-Line; 2012 Will Be A Year of Slugging It Out

Dec 21, 2011 03:22 PM Wells Fargo Cuts Valuation Range on Teva Pharma (TEVA) But Remains Bullish

Dec 19, 2011 08:45 AM Canaccord Genuity Maintains a 'Buy' on Teva Pharma (TEVA); 2012: Focus on Guidance, Cash Deployment. & Valuation

Back to TEVA Stock Lookup